Y. Yoneshima
发表
Y. Nakanishi,
I. Okamoto,
Kentaro Tanaka,
2019,
Lung cancer.
Y. Hosomi,
M. Ando,
M. Kondo,
2022,
Journal of Thoracic Oncology.
Y. Nakanishi,
I. Okamoto,
Kentaro Tanaka,
2021,
Lung cancer.
K. Akashi,
T. Miyamoto,
Y. Nakanishi,
2020,
Cancer science.
Y. Hosomi,
M. Ando,
M. Kondo,
2017,
Clinical lung cancer.
H. Nakanishi,
K. Sakumi,
Y. Nakabeppu,
2020,
JCI insight.
Y. Maehara,
Y. Oda,
Y. Nakanishi,
2018,
Surgical oncology.
Y. Hosomi,
Y. Ohe,
M. Ando,
2020,
JAMA oncology.
Y. Nakanishi,
K. Takayama,
I. Okamoto,
2015,
Lung cancer.
S. Anai,
Y. Nakanishi,
T. Koga,
2012,
Internal medicine.
Y. Nakanishi,
I. Okamoto,
M. Mori,
2022,
BMC Cancer.
T. Noda,
K. Sakumi,
Y. Nakabeppu,
2016,
Scientific Reports.
S. Anai,
Y. Nakanishi,
I. Okamoto,
2018,
Lung cancer.
N. Hamada,
Y. Nakanishi,
Koichiro Matsumoto,
2020,
International immunology.
Y. Hosomi,
M. Ando,
M. Kondo,
2022,
Clinical lung cancer.
Y. Oda,
N. Hamada,
Y. Nakanishi,
2018,
Oncotarget.
S. Hirano,
H. Sugiyama,
S. Nakamichi,
2018,
Respiratory investigation.
N. Hamada,
Y. Nakanishi,
I. Okamoto,
2021,
Translational lung cancer research.
Y. Oda,
Y. Nakanishi,
I. Okamoto,
2020,
Lung cancer.
Mutant forms of EGFR promote HER2 trafficking through efficient formation of HER2-EGFR heterodimers.
Y. Nakanishi,
I. Okamoto,
Kentaro Tanaka,
2022,
Lung cancer.
I. Okamoto,
Kensaku Ito,
Taichi Matsubara,
2020,
Lung cancer.
Y. Oda,
Y. Nakanishi,
G. Toyokawa,
2020,
Journal of Cancer Research and Clinical Oncology.
Y. Nakanishi,
I. Okamoto,
Kentaro Tanaka,
2018,
Lung cancer.
Y. Oda,
N. Hamada,
S. Fukuyama,
2020,
Internal medicine.
I. Okamoto,
Taichi Matsubara,
N. Haratake,
2021,
Cancer Immunology, Immunotherapy.
I. Okamoto,
Taichi Matsubara,
N. Haratake,
2020,
International journal of cancer.
Y. Nakanishi,
K. Takayama,
I. Okamoto,
2015,
Investigational New Drugs.
Y. Nakanishi,
I. Okamoto,
S. Takamori,
2021,
International journal of cancer.
Y. Oda,
Y. Nakanishi,
G. Toyokawa,
2019,
Scientific Reports.
Y. Nakanishi,
I. Okamoto,
H. Kohrogi,
2016,
Lung cancer.
I. Okamoto,
Kentaro Tanaka,
H. Inoue,
2022,
Cancer science.
Y. Nakanishi,
I. Okamoto,
Kentaro Tanaka,
2020,
Cancer science.
Y. Hosomi,
M. Ando,
M. Kondo,
2021
.
Y. Oda,
Y. Nakanishi,
I. Okamoto,
2021,
Lung cancer.
Y. Oda,
S. Anai,
Y. Nakanishi,
2018,
Lung cancer.
T. Ichiyama,
S. Furukawa,
T. Matsubara,
2003
.
Y. Nakanishi,
G. Toyokawa,
I. Okamoto,
2020,
Thoracic cancer.
K. Azuma,
H. Kenmotsu,
Toshiaki Takahashi,
2022,
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
Y. Hosomi,
M. Ando,
M. Kondo,
2021,
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
Y. Nakanishi,
I. Okamoto,
Kentaro Tanaka,
2020,
Lung cancer.
Y. Nakanishi,
I. Okamoto,
Kentaro Tanaka,
2019,
Clinical lung cancer.
S. Matsumoto,
K. Goto,
I. Okamoto,
2021,
Scientific Reports.
I. Okamoto,
Kentaro Tanaka,
Y. Yoneshima,
2021,
Clinical lung cancer.
N. Hamada,
I. Okamoto,
Tomohiro Ogawa,
2023,
Lung cancer.
C. Dooms,
Melissa L. Johnson,
S. Novello,
2023,
The Lancet.
K. Goto,
Jialei Wang,
D. Zhong,
2022,
Cancer Research.
Y. Oda,
I. Okamoto,
J. Kishimoto,
2021,
Translational lung cancer research.
Y. Nakanishi,
S. Masuda,
I. Okamoto,
2019,
Lung cancer.
I. Okamoto,
Kentaro Tanaka,
Y. Yoneshima,
2023,
Current Problems in Cancer: Case Reports.
Y. Oda,
N. Hamada,
Y. Nakanishi,
2019,
The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders.
Y. Nakanishi,
I. Okamoto,
H. Kohrogi,
2017
.
Y. Oda,
Hidetaka Yamamoto,
I. Okamoto,
2023,
Thoracic cancer.
Y. Hosomi,
Y. Ohe,
M. Ando,
2023,
Lung cancer.
Y. Oda,
T. Yoshizumi,
I. Okamoto,
2023,
Cancer science.
I. Okamoto,
Kentaro Tanaka,
Y. Yoneshima,
2023,
Frontiers in Immunology.
Y. Yoneshima,
E. Iwama,
R. Ibusuki,
2024,
NPJ precision oncology.
M. Maemondo,
J. Tanizaki,
S. Kitazono,
2024,
Japanese journal of clinical oncology.
Y. Yoneshima,
E. Iwama,
Y. Shiraishi,
2024,
Respiratory investigation.
K. Naoki,
T. Shimose,
Y. Yoneshima,
2024,
Thoracic cancer.
N. Inui,
T. Tamura,
M. Morise,
2023,
Advances in therapy.